Company Filing History:
2 out of 1,476 
2 out of 149 
1 out of 628 
Years Active: 2009-2022
Title: The Innovations of Peter Dröge
Introduction
Peter Dröge is a notable inventor based in Singapore, known for his contributions to the field of genetic engineering. He holds three patents that showcase his expertise in sequence-specific DNA recombination in eukaryotic cells. His work has significant implications for biotechnology and genetic research.
Latest Patents
One of Dröge's latest patents focuses on a method of sequence-specific recombination of DNA in eukaryotic cells. This invention involves the introduction of a first DNA comprising a nucleotide sequence containing at least one recombination sequence into a cell. Additionally, a second DNA with a nucleotide sequence containing at least one further recombination sequence is introduced into the cell. The sequence-specific recombination is then performed by a bacteriophage lambda integrase Int. This innovative approach has the potential to advance genetic manipulation techniques.
Career Highlights
Throughout his career, Peter Dröge has worked with prominent companies, including Boehringer Ingelheim Pharma KG. His experience in the pharmaceutical industry has allowed him to apply his inventive skills in practical settings, contributing to advancements in medical and biotechnological fields.
Collaborations
Dröge has collaborated with various professionals in his field, including Barbara Enenkel. These partnerships have fostered innovation and the exchange of ideas, further enhancing his contributions to science.
Conclusion
Peter Dröge's work in DNA recombination represents a significant advancement in genetic engineering. His patents and collaborations reflect his commitment to innovation in biotechnology. His contributions continue to influence the field and pave the way for future discoveries.